A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

EXEL surges 35.2% in three months as strong Cabometyx sales and zanzalintinib trial success fuel investor optimism.

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier ...

Is 24ot1jxa harmful? That’s the question buzzing around internet forums and health blogs lately, and honestly, it’s kinda ...

known active liver disease or abnormal liver function tests; (3) renal impairment; (4) inability to take medication enterally preoperatively; (5) use of feeding tube preoperatively; (6) current ...

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

A research team led by Prof. Hai Li from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has become the first to systematically explore how large language models (LLMs) can ...

Fatty liver disease affects more than 1 in 3 adults and often has no symptoms. A new drug developed with Tulane researchers ...

Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment by helping the immune system better find and attack ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.